Company / Operating Cash Flow
Biofrontera Inc. Operating Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$10.3M
FY2025
5-year range
-$26.7M / -$10.3M
FY2021-FY2025
Trend
+58.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 5 years, ranging from -$27M in FY2022 to -$10M in FY2025.
Based on SEC 10-K filings.
-$10M in FY2025.
Improved from -$16M to -$10M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 58.7% year-over-year.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.3M | +58.7% |
| FY2024 | -$24.9M | -53.7% |
| FY2023 | -$16.2M | +39.4% |
| FY2022 | -$26.7M | -116.0% |
| FY2021 | -$12.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026